CNS Response: The key to informed mental health treatment

One in four of us will suffer a diagnosable mental illness in a given year. And when that happens, our doctors will face a vast array of prescription drugs, with little more than symptoms to go on. No surprise, then, that treatment failures in disorders like depression range from 40-60%.

We were the first company to create biomarkers which predict the effectiveness of drugs based on the unique electrical signature of each person's brain. Some call it "personalized medicine".

We call it Referenced-EEG^®, a patented process which has helped thousands. In a series of clinical trials on patients who suffered for years without responding to treatment, physicians guided over 75% of them to medications that worked. Often the right medication was a novel combination of two medications. And sometimes, the right answer was no medication at all.

rEEG^® findings are presented in a brief,
2-page report which characterizes any
underlying abnormality in the brain, identifies resistance or sensitivity to major drug classes
and individual medications.